Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
PARP Inhibitors
>>
Phase 3
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
12
24
36
48
60
72
84
96
108
120
Talzenna
(talazoparib) / Pfizer
veliparib
(ABT-888) / AbbVie
Rubraca
(rucaparib) / Pharma& Schweiz
Partruvix
(pamiparib) / EMD Serono, BeiGene
iniparib
(BSI 201) / Sanofi
senaparib
(IMP4297) / IMPACT Therap
saruparib
(AZD5305) / AstraZeneca
ivospemin
(SBP-101) / Panbela Therap
Akeega
(abiraterone/niraparib) / J&J
